Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,578 | -15,577 | -83,795 | -35,465 | -89,127 |
| Depreciation Amortization | 8,971 | 6,860 | 4,724 | 2,445 | 7,575 |
| Accounts receivable | 9,387 | 8,137 | 8,136 | 6,783 | -7,602 |
| Accounts payable and accrued liabilities | 9,362 | 4,781 | 1,684 | 973 | -1,159 |
| Other Working Capital | 41,530 | 51,555 | -287 | -755 | -23,197 |
| Other Operating Activity | 3,016 | 2,795 | 347 | -3,477 | 19,900 |
| Operating Cash Flow | $6,688 | $58,551 | $-69,191 | $-29,496 | $-93,610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,566 | -7,988 | -3,896 | -1,342 | -591 |
| Purchase Of Investment | -95,971 | -66,342 | -51,942 | -46,944 | -218,284 |
| Sale Of Investment | 169,625 | 125,982 | 82,378 | 27,548 | 59,984 |
| Other Investing Activity | 0 | -750 | -750 | 0 | 0 |
| Investing Cash Flow | $64,088 | $50,902 | $25,790 | $-20,738 | $-158,891 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -948 | 0 | 0 | 0 | N/A |
| Common Stock Issued | 2,126 | 1,958 | 1,349 | 764 | 283,524 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 19,900 |
| Financing Cash Flow | $1,178 | $1,958 | $1,349 | $764 | $303,424 |
| Exchange Rate Effect | -1 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 116,049 | 116,049 | 116,049 | 116,049 | 65,126 |
| End Cash Position | 188,002 | 227,460 | 73,997 | 66,579 | 116,049 |
| Net Cash Flow | $71,954 | $111,411 | $-42,052 | $-49,470 | $50,923 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,688 | 58,551 | -69,191 | -29,496 | -93,610 |
| Capital Expenditure | -9,566 | -7,988 | -3,896 | -1,342 | -591 |
| Free Cash Flow | -2,878 | 50,563 | -73,087 | -30,838 | -94,201 |